Evidence map›Paper›PMID 25813705›Full record

ArticleNeuroscience2015

Nicotine modulates neurogenesis in the central canal during experimental autoimmune encephalomyelitis.

Z Gao, J C Nissen, L Legakis, S E Tsirka

Open access · greenAbstract read
In one paragraph

Article in Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Phytochemicals derived fromFrontiers in pharmacology · 2024
    Review
  3. The Effects of Nicotine and Cannabinoids on Cytokines.Current pharmaceutical design · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Z GaoProgram in Neuroscience, Stony Brook University, Stony Brook, NY, United States; Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, United States.
J C NissenDepartment of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, United States.
L LegakisDepartment of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, United States.
S E TsirkaProgram in Neuroscience, Stony Brook University, Stony Brook, NY, United States; Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, United States. Electronic address: Styliani-anna.tsirka@stonybrook.edu.
Stony Brook University · US

Funding

IRACDA - The New York Consortium for the Advancement of Postdoctoral Scholars (NY CAPS)Phase IIK12GM102778 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI Carol A. Carter, Karian Janice Wright · 2012 to 2026
$13.1M
Microglial effector pathways in the CNSR01NS042168 · NINDS · STATE UNIVERSITY NEW YORK STONY BROOK · PI TSIRKA, STYLIANI-ANNA (STELLA) E · 2003 to 2011
$3.1M
NIGMS NIH HHS K12 GM102778NIGMS NIH HHS K12GM102778NINDS NIH HHS R01 NS042168NINDS NIH HHS R01NS42168
6 · The paper itself

Abstract

Nicotine has been shown to attenuate experimental autoimmune encephalomyelitis (EAE) through inhibiting inflammation in microglial populations during the disease course. In this study, we investigated whether nicotine modified the regenerative process in EAE by examining nestin-expressing neural stem cells (NSCs) in the spinal cord, which is the primary area of demyelination and inflammation in EAE. Our results show that the endogenous neurogenic responses in the spinal cord after EAE are limited and delayed: while nestin expression is increased, the proliferation of ependymal cells is inhibited compared to healthy animals. Nicotine application significantly reduced nestin expression and partially allowed for the proliferation of ependymal cells. We found that reduction of ependymal cell proliferation correlated with inflammation in the same area, which was relieved by the administration of nicotine. Further, increased numbers of oligodendrocytes (OLs) were observed after nicotine treatment. These findings give a new insight into the mechanism of how nicotine functions to attenuate EAE.

Indexed as

AnimalsAntigensAutophagy-Related ProteinsChondroitin Sulfate Proteoglycan 4Doublecortin Domain ProteinsEncephalomyelitis, Autoimmune, ExperimentalGlial Fibrillary Acidic ProteinInflammationIntracellular Signaling Peptides and ProteinsKi-67 AntigenLeukocyte Common AntigensMiceMice, Inbred C57BLMicrotubule-Associated ProteinsMyelin-Oligodendrocyte GlycoproteinNerve DegenerationAntigensAutophagy-Related ProteinsChondroitin Sulfate Proteoglycan 4Doublecortin Domain ProteinsGlial Fibrillary Acidic ProteinIntracellular Signaling Peptides and ProteinsKi-67 AntigenLeukocyte Common AntigensMicrotubule-Associated ProteinsMyelin-Oligodendrocyte Glycoproteinmyelin oligodendrocyte glycoprotein (35-55)NestinNeuropeptidesNicotineNicotinic AgonistsPeptide FragmentsProteoglycansRb1cc1 protein, mousecentral canalEAEneural stem cellsnicotineoligodendrocytes

Identifiers

PMID25813705
PMCPMC4428965
OpenAlexW2082930581

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.